Chembio Diagnostics Inc (CEMI.OQ)
CEMI.OQ on NASDAQ Stock Exchange Capital Market
6.97USD
24 May 2019
6.97USD
24 May 2019
Change (% chg)
$-0.12 (-1.69%)
$-0.12 (-1.69%)
Prev Close
$7.09
$7.09
Open
$7.23
$7.23
Day's High
$7.23
$7.23
Day's Low
$6.88
$6.88
Volume
7,648
7,648
Avg. Vol
16,349
16,349
52-wk High
$11.55
$11.55
52-wk Low
$4.87
$4.87
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 8.30 | -0.164 |
| FY 2018 | Dec '18 | 7.59 | -0.197 |
| Sep '18 | 9.38 | -0.163 | |
| Jun '18 | 8.72 | -0.122 | |
| Mar '18 | 7.72 | -0.049 | |
| FY 2017 | Dec '17 | 5.99 | -0.162 |
| Sep '17 | 7.59 | -0.047 | |
| Jun '17 | 4.11 | -0.177 | |
| Mar '17 | 6.33 | -0.132 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 5 | 8.78 | 9.14 | 8.40 | 9.85 |
| Quarter Ending Sep-19 | 5 | 10.54 | 11.62 | 9.65 | 9.85 |
| Year Ending Dec-19 | 5 | 37.82 | 38.98 | 37.00 | 42.77 |
| Year Ending Dec-20 | 5 | 49.43 | 61.40 | 44.00 | 59.99 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 5 | -0.15 | -0.11 | -0.17 | -0.03 |
| Quarter Ending Sep-19 | 5 | -0.12 | -0.10 | -0.14 | -0.03 |
| Year Ending Dec-19 | 5 | -0.56 | -0.48 | -0.63 | -0.08 |
| Year Ending Dec-20 | 5 | -0.13 | 0.11 | -0.32 | 0.47 |
| LT Growth Rate (%) | 1 | 25.00 | 25.00 | 25.00 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 31.17 | 35.48 | |
| P/E High - Last 5 Yrs. | -- | 50.33 | 57.43 | |
| P/E Low - Last 5 Yrs. | -- | 27.08 | 28.10 | |
| Beta | 1.86 | 0.96 | 0.95 | |
| Price to Sales (TTM) | 3.52 | 7.53 | 9.28 | |
| Price to Book (MRQ) | 3.85 | 3.58 | 4.15 | |
| Price to Tangible Book (MRQ) | 5.33 | 3.87 | 4.94 | |
| Price to Cash Flow (TTM) | -- | 22.40 | 24.38 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.86 | 1.68 | |
| Dividend Yield - 5 Year Avg | -- | 1.41 | 1.30 | |
| Dividend 5 Year Growth Rate | -- | 6.56 | 6.71 | |
| Payout Ratio(TTM) | -- | 39.75 | 35.42 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 7.57 | 14.95 | 16.40 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 33.79 | 6.25 | 8.26 | |
| Sales - 5 Yr. Growth Rate | 2.49 | 9.16 | 10.27 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -233.68 | 19.17 | 19.71 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -48.34 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 5.66 | 7.23 | |
| Capital Spending - 5 Yr. Growth Rate | 10.62 | 7.28 | 8.25 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.38 | 2.42 | 2.43 |
| Current Ratio (MRQ) | 3.73 | 3.38 | 3.36 |
| LT Debt to Equity (MRQ) | 0.46 | 13.50 | 14.37 |
| Total Debt to Equity (MRQ) | 1.12 | 18.38 | 19.78 |
| Interest Coverage (TTM) | -- | 7.80 | 13.53 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 35.29 | 51.81 | 50.23 | |
| Gross Margin - 5 Yr. Avg. | 41.53 | 50.55 | 51.31 | |
| EBITD Margin (TTM) | -25.46 | -- | -- | |
| EBITD - 5 Yr. Avg | -16.78 | 17.44 | 15.84 | |
| Operating Margin (TTM) | -30.67 | 0.98 | -4.60 | |
| Operating Margin - 5 Yr. Avg. | -21.34 | 13.61 | 11.09 | |
| Pre-Tax Margin (TTM) | -30.51 | 0.54 | -4.95 | |
| Pre-Tax Margin - 5 Yr. Avg. | -21.26 | 19.46 | 15.89 | |
| Net Profit Margin (TTM) | -29.51 | -3.11 | -8.72 | |
| Net Profit Margin - 5 Yr. Avg. | -24.47 | 14.63 | 11.14 | |
| Effective Tax Rate (TTM) | -- | 19.56 | 19.94 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.54 | 24.16 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 115,231 | 883,631,482 | 746,541,307 | |
| Net Income/Employee (TTM) | -33,999 | 103,176,553 | 87,192,468 | |
| Receivable Turnover (TTM) | 5.90 | 5.39 | 5.67 | |
| Inventory Turnover (TTM) | 2.81 | 2.51 | 3.66 | |
| Asset Turnover (TTM) | 0.92 | 0.82 | 0.79 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -27.01 | 9.71 | 9.44 | |
| Return on Assets - 5 Yr. Avg. | -26.89 | 10.97 | 10.47 | |
| Return on Investment (TTM) | -32.07 | 12.05 | 11.75 | |
| Return on Investment - 5 Yr. Avg. | -32.63 | 13.96 | 13.33 | |
| Return on Equity (TTM) | -36.58 | 13.36 | 16.52 | |
| Return on Equity - 5 Yr. Avg. | -32.97 | 15.26 | 14.90 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 39.12 | 11.26 | 2.49 |
| EPS (TTM) % | -5.21 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Chembio Diagnostics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -6.19 | -2.41 | 38 | 22 |
| 13 Week | 0.29 | -0.90 | 59 | 20 |
| 26 Week | 14.64 | 6.79 | 79 | 11 |
| 52 Week | -23.41 | -26.07 | 40 | 63 |
| YTD | 23.14 | 9.24 | 77 | 17 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 41.03% |
| # of Holders: | 50 |
| Total Shares Held: | 7,044,126 |
| 3 Mo. Net Change: | -624,127 |
| # New Positions: | 5 |
| # Closed Positions: | 7 |
| # Increased Positions: | 18 |
| # Reduced Positions: | 20 |
| # Net Buyers: | -2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.